Company Galapagos NV Euronext Bruxelles

Equities

GLPG

BE0003818359

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Sector Other Biotechnology & Medical Research

Inactive Instrument

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing innovative medicines. The company is committed to improving patients' lives worldwide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan.

EUR in Million	2022	Weight	2023	Weight	Delta
Medicines 100.0 %	505	100.0 %	240	100.0 %	-52.56%

EUR in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	414	82.0 %	240	100.0 %	-42.12%
Europe 0.0 %	91	18.0 %	0	0.0 %	-99.98%

Managers	Title	Age	Since
Paulus Stoffels CEO	Chief Executive Officer	62	22-03-31
Thad Huston DFI	Director of Finance/CFO	54	23-05-31
Sandra Cauwenberghs IRC	Investor Relations Contact	-	20-10-31
Valeria Cnossen LAW	General Counsel	51	22-07-31
Annelies Missotten HRO	Human Resources Officer	52	18-01-31
Annelies Denecker SEC	Corporate Secretary	-	-
Phil Dudfield PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Andrew Dickinson BRD	Director/Board Member	54	Mar. 26
Jérôme Contamine BRD	Director/Board Member	66	22-04-25
Simon Sturge BRD	Director/Board Member	65	23-09-18
Linda Higgins BRD	Director/Board Member	62	19-10-21
Paulus Stoffels CEO	Chief Executive Officer	62	22-03-31
Susanne Antonie Schaffert BRD	Director/Board Member	57	23-06-11
Peter Guenter BRD	Director/Board Member	61	19-04-29
Lena Elisabeth Svanberg BRD	Director/Board Member	63	20-04-27
Dan Baker BRD	Director/Board Member	74	22-04-25

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	65,897,071	49,184,974 ( 74.64 %)	0	74.64 %

Name	Equities	%	Valuation
GILEAD SCIENCES, INC. 25.35 %	16,707,477	25.35 %	418 M €
Van Herk Investments BV 7.035 %	4,635,672	7.035 %	116 M €
De Grote Voskuil Capital BV 0.2732 %	180,000	0.2732 %	5 M €
Thornbridge Investment Management LLP 0.2424 %	159,740	0.2424 %	4 M €
Econopolis Wealth Management NV 0.1214 %	80,000	0.1214 %	2 M €
Saint Olive Gestion SNC 0.0645 %	42,500	0.0645 %	1 M €
Mercer Global Investments Europe Ltd. 0.0441 %	29,052	0.0441 %	726 726 €
GLS Investment Management GmbH 0.0379 %	25,000	0.0379 %	625 366 €
CAPFI DELEN Asset Management NV 0.0354 %	23,305	0.0354 %	582 966 €
Scottish Widows Schroder Person Wealth (ACD) Ltd. 0.0260 %	17,105	0.0260 %	427 876 €

Name	Equities	%	Valuation
EcoR1 Capital, LLC 8.735 %	5,756,268	8.735 %	143 M €
Fidelity Management & Research Co. LLC 6.335 %	4,174,517	6.335 %	103 M €
BVF, Inc. 2.828 %	1,863,809	2.828 %	46 M €
Deerfield Management Co. LP (Private Equity) 2.141 %	1,411,000	2.141 %	35 M €
Prosight Management LP 1.414 %	931,512	1.414 %	23 M €
Segall Bryant & Hamill LLC 1.317 %	868,042	1.317 %	22 M €
PRIMECAP Management Co. 1.085 %	715,240	1.085 %	18 M €
BlackRock Advisors LLC 0.7706 %	507,798	0.7706 %	13 M €
Finepoint Capital LP 0.7645 %	503,759	0.7645 %	12 M €
Wellington Trust Co., NA 0.7206 %	474,883	0.7206 %	12 M €

Galapagos NV

Industriepark Mechelen Noord Generaal de Wittelaan L11 A3

2800, Mechelen

+32 1 534 29 00

http://www.glpg.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+22.10%	46.55B
LONZA GROUP AG	+46.45%	41.84B
IQVIA HOLDINGS INC.	-3.12%	40.84B
ALNYLAM PHARMACEUTICALS, INC.	+36.10%	32.95B
CELLTRION, INC.	-6.30%	28.27B
ICON PUBLIC LIMITED COMPANY	+18.71%	27.78B
UNITED THERAPEUTICS CORPORATION	+46.15%	14.26B
MEDPACE HOLDINGS, INC.	+44.52%	13.69B
BIO-TECHNE CORPORATION	+0.19%	12.18B

Other Biotechnology & Medical Research